Masashi Miyamoto
President and Chief Executive Officer(CEO)

We would like to sincerely congratulate Health and Global Policy Institute (HGPI) on its remarkable 20th anniversary.

In the field of health and medicine where HGPI operates, under our management philosophy of “the Kyowa Kirin Group companies strive to contribute to the health and well-being of people around the world by creating new value through the pursuit of advances in life sciences and technologies,” and as a Japan-based Global Specialty Pharmaceutical Company, we are striving to utilize diverse drug discovery technologies, such as our unique antibody technologies, to discover innovative new drugs that will make patients and their caregivers smile.

We have designated as our vision for 2030, “Kyowa Kirin will realize the successful creation and delivery of life-changing value that ultimately makes people smile, as a Japan-based Global Specialty Pharmaceutical Company built on the diverse team of experts with shared passion for innovation.” By identifying unmet medical needs and creating new pharmaceuticals and solutions to meet those needs, and by innovating across the company, it is Kyowa Kirin’s aim to create life-changing value that brings smiles to people suffering from disease and gives them hope that their lives can change dramatically for the better.

We deeply respect the passionate activities in the health and medical fields that HGPI has woven since its establishment, and the numerous achievements that have emerged both domestically and internationally from these efforts. We also wish for the continued growth and success of your organization in realizing a healthier and more prosperous society for people. Congratulations on your 20th anniversary.

　■Company information
　Kyowa Kirin Co., Ltd.
　https://www.kyowakirin.com/index.html